Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
20-September-2008 09:55:51 - Cancer vaccine The term cancer vaccine refers to a vaccine that either prevents infections with cancer-causing viruses, or treats existing cancer. Some cancers, such as cervical cancer and some liver cancers, are caused by viruses, and traditional vaccines against those viruses, such as HPV vaccine and Hepatitis B vaccine, will prevent those cancers. Scientists have also been trying to develop vaccines against existing cancers. Some researchers believe that cancer cells routinely arise and are destroyed by the healthy immune system; cancer forms when the immune system fails to destroy them. They are separating proteins from cancer cells and immunizing cancer patients against those proteins, in the hope of stimulating an immune reaction that would kill the cancer cells. Therapeutic cancer vaccines are being developed for the treatment of breast, lung, colon, skin, kidney, prostate, and other cancers.1 But they have not yet been proven to work in phase 3 human trials, and have not been approved by the U.S. Food and Drug Administration or by European Union regulatory agencies.2 Contents 1 Problems 1.1 Drug Development 2 References 3 External links Problems A vaccine against a particular virus is relatively easy to create. The virus is foreign to the body, and therefore will express antigens the immune system can recognize. Furthermore, there are usually only a few viable variants of the virus in question. It is very hard to develop vaccines for viruses that mutate constantly such as influenza or HIV. A tumour can have many different types of cells in it, each with different cell-surface antigens. Furthermore, those cells are derived from the individual with cancer, and therefore display few if any antigens that are foreign to that individual. This makes it difficult for the immune system to distinguish the cancer cells from normal cells. Renal cancer and melanoma are the two cancers with most evidence of causing spontaneous and effective immune responses, possibly because they often display antigens that are recognized as foreign. Therefore, many attempts at developing cancer vaccines are directed against these tumors. However, most clinical trials investigating a cancer vaccine against melanoma and renal cancer have failed. The precise reasons are unknown, but possible explanations include: 1 disease stage being treated was too advanced it is difficult to get the immune system to fight bulky tumor deposits, the most suitable stage for a cancer vaccine is likely to be minimal residual disease 2 escape loss variants cancer vaccines that target just one tumor antigen are likely to be less effective. Tumors are highly heterogeneous and antigen expression differs markedly between tumors even within deposits in the same patient. The most effective cancer vaccine is likely to raise an immune response against a broad range of tumor antigens to minimise the chance of the tumor being able to mutate and become resistant to the therapy. 3 prior treatments numerous clinical trials in the past have treated patients who have received numerous cycles of chemotherapy. Chemotherapy is often myelosuppressive and destroys the immune system. There is little point giving a cancer vaccine to a patient who is immune suppressed. Drug Development Most of the cancer vaccines in development are addressing specific cancer types and are therapeutic vaccines. Several cancer vaccines are currently in development by companies such as Genitope Corp MyVax personalized immunotherapy, Onyvax Limited1 Onyvax-P, Antigenics Inc. Oncophage, Geron Corporation GRNVAC1, Favrille Inc FavId, Dendreon Corp Provenge, Cell Genesys Inc GVAX,Advaxis, Inc Lovaxin C,Accentia Biopharmaceuticals majority owned subsidiary Biovest International BiovaxID, GeneMax Corp GMXX and Apthera, Inc.2 NeuVax. On April 8 2008, New York-based company Antigenics announced that it had received approval for the first therapeutic cancer vaccine in Russia. It is the first approval by a regulatory body of a cancer immunotherapy. The treatment, Oncophage, increased recurrence-free survival by a little more than a year according to the results of a phase III clinical trial. It awaits approval in the US and EU.3 References ^ Giarelli E 2007. Cancer vaccines: a new frontier in prevention and treatment. Oncology Williston Park 21 11 Suppl Nurse Ed: 11-8. PMID 18154203. ^ National Cancer Institute, Cancer Vaccine Fact Sheet, Updated: 06/08/2006 ^ The Scientist : NewsBlog : 1st cancer vaccine approved in Russia 9th April 2008 External links Cancer Vaccine Consortium International Society for Biological Therapy of Cancer v d e Vaccines, Vaccination, Immunization, and Inoculation see also artificial induction of immunity Development Adjuvants Cancer vaccines DNA vaccination HIV Live vector vaccine Models Timeline Trial Administration Global: GAVI Policy Schedule Vaccine injury USA: ACIP VAERS VSD Vaccine court Vaccines live Anthrax BCG tuberculosis Flu MMR MMRV PolioOPV Rotavirus Smallpox Varicella Yellow fever Inactivated/toxoid inactivated virus: Flu HAV PolioIPV inactivated bacteria/toxoid: DTwP conjugate: Hib PCV Other subunit: Anthrax DTaP HPV recombinant DNA: HBV other: Anthrax PPV Controversy General A-CHAMP MMR NCVIA Pox party Safe Minds Thiomersal See also List of vaccine topics Epidemiology Eradication of infectious diseases Retrieved from http://en..org/wiki/Cancer_vaccine Categories: Vaccination | Oncology | Cancer treatments Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages БългарÑ?ки اردو This page was last modified on 9 August 2008, at 19:47
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie video
The Power of You video
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.